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In an epidemiological study, mimivirus was reported as an 
unlikely cause of human respiratory infections in China. Our 
analysis revealed the nonsensitivity of the PCR method, 
which detected less than 10% of the current known mimivi-
rus. We conclude that epidemiologic studies must use ac-
curate and sensitive laboratory test methods.
The article by Zhang et al. (1) reporting the failure to detect mimivirus (Acanthamoeba polyphaga mimi-
virus) in patients with acute respiratory symptoms was 
flawed in 2 ways. First, a single mimivirus was detected 
by PCR but was dismissed by the authors as colonization. 
Second, and of greater concern, the PCR used by the au-
thors would not detect most known mimiviruses because 
of primer/probe mismatches. In fact, PCRs used in most 
mimivirus prevalence studies would fail to detect most 
mimiviruses, given the extensive genome sequence diver-
sity of these viruses (2). 
We evaluated the PCR primers/probes used by Zhang 
et al. (1) for sequence similarity with 51 mimivirus genomes 
available in the public domain since March 2016, the date 
on which the article by Zhang et al. was submitted (3). Our 
in silico analysis found that none of the 25 genomes avail-
able from lineage A and 7 genomes from lineage B were 
complementary with their primers and probes, and only 5 
of 19 lineage C genomes showed sufficient sequence simi-
larity to permit successful amplification (Table). Overall, 
the PCR used by these authors would be predicted to detect 
only ≈26% of lineage C mimiviruses and <10% of pub-
lished mimivirus genomes overall.
As proposed by Ngounga et al. (4), the great variabil-
ity across the 3 lineages of mimivirus genomes requires 
the design of lineage-specific primers to improve PCR 
sensitivity (4). Until PCRs are improved, mimiviruses 
might be best detected by metagenomic approaches that 
have recently seen success in terms of mimivirus detec-
tion. For example, mimivirus-like reads have been identi-
fied by metagenomics in 1 (8%) of 12 fecal samples from 
children with acute diarrhea (5); 5 (27%) of 18 prostatic 
secretion samples from persons with prostatitis (6); all 
DNA libraries tested from the plasma of patients with 
hepatitis (7); 0.0018% of total viral reads from nasopha-
ryngeal samples from 210 patients with respiratory tract 
symptoms (8); and all tested fecal, mid-vaginal, buccal 
mucosal, and retroauricular crease samples, with a pre-
dominance of mimiviruses in fecal samples reaching 
≈33% of the total viral reads (9). 
In metagenomics approaches, the number of reads de-
tected and the distribution along the whole viral genome 





Table. Mimivirus genomes in the public domain screened to determine whether the genomes were complementary with their 
primers/probes* 
Lineage A (GenBank accession no.) Lineage B (GenBank accession no.) Lineage C (GenBank accession no.) 
Mimivirus fauteuil (CWKE00000000) Moumouvirus ochan (CXPE00000000) Megavirus shan (CWIL00000000) 
Mimivirus longchamps (CXOV00000000) Moumouvirus istres (PRJEB9189) Megavirus montpellier3 (CWIA00000000) 
Mimivirus marais (PRJEB9199) Moumouvirus battle49 (CXOS00000000) Megavirus mont1 (CWIO00000000) 
Mimivirus lactours (CXOL00000000) Moumouvirus saoudian (CXOQ00000000) Megavirus avenue9 (CWHN00000000) 
Mimivirus PointeRouge1 (CXOW00000000) Moumouvirus boug1 (PRJEB9190) Megavirus balcon (PRJEB9194) 
Mimivirus PointeRouge2 (CXOU00000000) Moumouvirus goulette (KC008572) Megavirus ursino (CWJY00000000) 
Mimivirus T3 (CXOR00000000) Moumouvirus Monve (JN885994–
JN886001) 
Megavirus T1 (CWIB00000000) 
Mimivirus huitre A06 (CWJT00000000) Megavirus battle43 (CWHV00000000) 
Mimivirus amazonia (CWHO00000000) 
 
Megavirus T4 (CWJR00000000) 
Mimivirus battle7 (CWJW00000000) 
 
Megavirus J3 (CWIN00000000) 
Mimivirus battle19 (CWJX00000000) 
 
Megavirus T6 (CWJQ00000000) 
Mimivirus battle27 (CWJS00000000) 
 
Megavirus chilensis (NC_016072) 
Mimivirus battle57 (CWJZ00000000) 
 
Megavirus courdo11 (JX975216) 
Mimivirus battle66 (CWKA00000000) 
 
Megavirus lba† (JX885207) 
Mimivirus battle83 (CWKG00000000) 
 
Powai lake megavirus (KU877344) 
Mimivirus battle86 (CWKD00000000) 
 
Megavirus terra1 (KF527229) 
Mimivirus T2 (CXOT00000000) 
 
Megavirus courdo5 (CWID00000000) 
Mimivirus battle6 (CWJU00000000) 
 
Megavirus bus (CWIQ00000000) 
Mimivirus dakar4 (CWKF00000000) 
 
Megavirus courdo7 (JN885990–
JN885993) Mimivirus (AY653733) 
 
Mimivirus Bombay (KU761889) 
  
Mimivirus terra 2 (PRJNA240235) 
  
Samba virus (KF959826) 
  




*Bold indicates genomes that would be predicted to be successfully amplified using the PCR primers and probes in the article by Zhang et al. (1). 
†Mimiviruses isolated from human samples. 
 
are essential parameters for viral detection. In practice, the 
search for mimivirus is complicated by the great genetic 
variability of the virus and the restricted availability of 
mimivirus culture systems to a few research laboratories 
(10). The deficiencies we found in the report by Zhang et 
al. highlight the need for carefully designed epidemiologic 
studies using sensitive laboratory test methods to accu-
rately assess mimivirus prevalence and the potential role of 
mimivirus in human disease.
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We report a case of a 54-year-old Moroccan woman living 
in France diagnosed with eosinophilic meningitis caused 
by Angiostrongylus cantonensis. Diagnosis was based on 
clinical symptoms and confirmed by testing of serum and 
cerebrospinal fluid samples. Physicians should consider the 
risk for A. cantonensis infection outside of endemic areas.
Angiostrongylus cantonensis is a rat lungworm that has long been recognized as a cause of eosinophilic meningitis in 
Southeast Asia, the Pacific Islands, and the Caribbean, where 
it is endemic (1). Although sporadic imported cases have been 
described in European travelers (2–5), no autochthonous case 
of eosinophilic meningitis caused by A. cantonensis worms 
has been reported previously in metropolitan France.
A 54-year-old Moroccan woman was admitted to an 
emergency ward in Paris in 2016 because of fever and head-
ache lasting 2 weeks. She had a history of type 2 diabetes treat-
ed with metformin and did not receive any other medication 
before the onset of symptoms. She was a pesco-vegetarian and 
worked as a cleaning woman in an office in Paris. She had 
taken up residence near Paris in the 1980s and had not trav-
eled out of France since, except for Morocco over 2 years ago.
At admission, her blood pressure was 126/68 mm Hg, 
and her pulse was regular at 79 beats/min. The physical 
examination revealed meningeal signs with neck stiffness 
and photophobia without neurologic localization signs. No 
other clinical abnormality could be evidenced. Laboratory 
testing of serum showed a leukocyte count of 12.1 × 109 
cells/L (reference range 4.5–11.0 × 109/L) with 18% (2.2 
× 109 cells/L) eosinophils and a C-reactive protein of 73 
mg/dL (reference range 0.08–3.1 mg/L). Cerebrospinal 
fluid (CSF) analysis showed a leukocyte count of 950 cells/
µL with 56% eosinophils, a glucose concentration within 
reference range at 0.4 g/L, and an elevated protein level 
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